MannKind Corporation (MNKD) Financial Statements (2024 and earlier)

Company Profile

Business Address 1 CASPER STREET
DANBURY, CT 06810
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments170,846204,11667,00549,88471,15743,946
Cash and cash equivalents69,767124,18467,00529,90671,15743,946
Short-term investments101,07979,932 19,978  
Restricted cash and investments   1583165274,409
Receivables16,8014,9944,2183,5134,0172,789
Inventory, net of allowances, customer advances and progress billings21,7727,1524,9734,1553,5972,657
Inventory21,7727,1524,9734,1553,5972,657
Deferred costs      405
Other undisclosed current assets25,4773,4823,1222,8892,5563,010
Total current assets:234,896219,74479,47660,75781,85457,216
Noncurrent Assets
Property, plant and equipment45,12636,61225,86726,77825,60226,922
Long-term investments and receivables1,96156,619    
Long-term investments1,96156,619    
Intangible assets, net (including goodwill)3,581     
Goodwill2,428     
Intangible assets, net (excluding goodwill)1,153     
Other noncurrent assets9,7188,1863,2656,190249437
Total noncurrent assets:60,386101,41729,13232,96825,85127,359
TOTAL ASSETS:295,282321,161108,60893,725107,70584,575
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities46,60534,37525,28920,69320,40119,433
Accounts payable11,0526,9565,5824,7895,3796,984
Accrued liabilities35,55327,41919,70715,90415,02212,449
Deferred revenue1,73382733,27532,503
Debt9,5656,977 5,02811,29852,745
Deferred revenue and credits3,038
Contract with customer, liability36,885
Other undisclosed current liabilities9,3936,17015,1417,3946,65712,381
Total current liabilities:67,29648,34973,70565,61875,24187,597
Noncurrent Liabilities
Long-term debt and lease obligation319,909318,5096,2027,51419,09924,411
Long-term debt, excluding current maturities225,397223,9445,0005,00019,09924,411
Finance lease, liability94,51293,525  
Liabilities, other than long-term debt51,85642,91864,68978,36482,76979,666
Deferred revenue37,68419,5431,6628,344
Contract with customer, liability10,680
Due to related parties8,82918,42563,02770,02072,08979,666
Other liabilities  4,950    
Operating lease, liability5,3431,0401,2022,514
Other undisclosed noncurrent liabilities106,759120,734144,431132,755105,678107,633
Total noncurrent liabilities:478,524482,161215,322218,633207,546211,710
Total liabilities:545,820530,510289,027284,251282,787299,307
Equity
Equity, attributable to parent(250,538)(209,349)(180,419)(190,526)(175,082)(214,732)
Common stock2,6382,5152,4212,1181,8701,192
Additional paid in capital2,964,2932,918,2052,866,3032,799,2782,763,0672,638,992
Accumulated other comprehensive income (loss)   (19)(19)(18)
Accumulated deficit(3,217,469)(3,130,069)(3,049,143)(2,991,903)(2,940,000)(2,854,898)
Total equity:(250,538)(209,349)(180,419)(190,526)(175,082)(214,732)
TOTAL LIABILITIES AND EQUITY:295,282321,161108,60893,725107,70584,575

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues99,77075,44265,14463,03827,85911,745
Revenue, net11,745
Cost of revenue(106,383)(28,414)(30,498)(25,094)(19,402)(26,926)
Cost of goods and services sold(16,003)(16,833)(15,084)(20,078)(19,402)(20,199)
Gross profit:(6,613)47,02834,64637,9448,457(15,181)
Operating expenses(57,497)(94,050)(82,559)(82,541)(88,453)(93,008)
Other undisclosed operating income     3,401 
Operating loss:(64,110)(47,022)(47,913)(44,597)(76,595)(108,189)
Nonoperating expense(23,290)(33,904)(9,545)(7,306)(10,140)(9,093)
Investment income, nonoperating2,513112167997501293
Interest and debt expense(9,552)(17,200)(264)3,529(46)(31)
Loss from continuing operations before equity method investments, income taxes:(96,952)(98,126)(57,722)(48,374)(86,781)(117,313)
Other undisclosed income (loss) from continuing operations before income taxes9,55217,200264(3,529)4631
Loss from continuing operations before income taxes:(87,400)(80,926)(57,458)(51,903)(86,735)(117,282)
Income tax expense (benefit) 9,94019,6312185,252(240)(51)
Other undisclosed income from continuing operations      
Loss from continuing operations:(77,460)(61,295)(57,240)(46,651)(86,975)(117,333)
Loss before gain (loss) on sale of properties:(61,295)(57,240)(46,651)(86,975)(117,333)
Other undisclosed net loss(9,940)(19,631) (5,252)  
Net loss available to common stockholders, diluted:(87,400)(80,926)(57,240)(51,903)(86,975)(117,333)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(87,400)(80,926)(57,240)(51,903)(86,975)(117,333)
Comprehensive loss:(87,400)(80,926)(57,240)(51,903)(86,975)(117,333)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (19) (1)6
Comprehensive loss, net of tax, attributable to parent:(87,400)(80,926)(57,259)(51,903)(86,976)(117,327)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: